Bristol-Myers Squibb Company, through its subsidiaries, engages in the discovery, development, licensing, manufacturing, marketing, distribution, and sale of pharmaceuticals and nutritional products. The company operates in two segments, Pharmaceuticals, and Nutritionals. The Nutritionals segment is operated through the company's subsidiary Mead Johnson Nutrition Company (Mead Johnson). The Pharmaceuticals segment is made up of the global pharmaceutical and international consumer medicines business.

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

Secretary of State for Defence is a private company headquartered in the United Kingdom with subsidiaries in that country. The firm operates as a state secretary of defense.

The Institute Pasteur is a private, non-profit foundation. Its mission is to help prevent and treat diseases, mainly those of infectious origin, through research, teaching, and public health initiatives.The Institut Pasteur is a research center of international renown ideally located in the very heart of Paris. Each year the institute hosts a multitude of scientific and medical conferences and meetings as well as events on a variety of themes.

Fujirebio, Inc. engages in the manufacture, sale, import and export of clinical diagnostic reagents and assay instruments. It also provides diagnostic, clinical laboratory testing and related services. The company was founded on December 18, 1950 and is headquartered in Tokyo, Japan.

Enigma Diagnostics Ltd. develops next generation rapid molecular diagnostic instrument platforms for decentralized and point-of-care settings. It offers Enigma Instruments, Enigma MiniLab, and Enigma technology and IP. The firm has operation in Salisbury and San Diego. The company was founded in 2004 and is headquartered in Salisbury, the United Kingdom.

Albright & Wilson (Australia) Ltd. produces detergent and other chemical products. It offers food & beverage products, household, personal care and i&i products and industrial, mining & agriculture products. The company was founded in 1939 and is headquartered Yarraville, Australia.

Akzo Nobel NV is a holding company, which engages in the manufacture and sale of coating and paint products. engages in the production and marketing of paints and coatings. It operates through the following segments: Decorative Paintings, Performance Paintings, and Corporate and Others. The Decorative Paints segment manufactures and supplies a range of interior and exterior decoration and protection products for professional and do-it-yourself markets. The Performance Coatings segment produces automotive and aerospace; industrial; marine and protective; and powder coatings. The company was founded in 1792 and is headquartered in Amsterdam, Netherlands.

Chundsell Medicals AB was founded in 2007 as a spin off from Karolinska Institutet, Solna, in order to commercialize the research results of Chunde Li and his group on prostate cancer genomics. The first product: The Prostatype® Test System can assess prostate cancer aggressiveness in conjunction with currently used clinical parameters. The Prostatype® Test System measures the expression pattern of three selected and specific prostate cancer embryonic stem cell genes in tumor cell tissue specimens. These expression patterns together with a group of a selected number of known clinical parameters will help the health care professional to predict the disease outcome, the overall survival as well as cancer specific survival of patients.

Molecular Biosystems, Inc. develops, makes and sells ultrasound contrast imaging agents. The company was founded by Kenneth J. Widder, Richard H. Tullis, Drew E. Senyei and Lyle J. Arnold and is headquartered in San Diego, CA.

Guangzhou Funeng Gene Co., Ltd., established on 2000-05-11, Business scope includes manufacturing of chemical reagents and additives(Monitor Chemicals,Excluding hazardous chemicals);Biotechnology Extension Services;Biotechnology Consulting,communication service;Biotechnology Transfer Services;Biotechnology Development Services;

Promega Contributing to the prevention, healing and more. Founded in 1978, which began with the production of enzymes for research, has evolved into a catalog of over 2,000 products for a wide range of applications, including basic research, drug discovery, forensics, paternity testing and diagnosis clinician.

Manufactures liquid packaging board, fluff pulp and sack paper

The Research Authority serves as the administrative and financial framework for research activities, scientific experiments and technical analyses carried out by Technion faculty, and TRDF staff. The missions of the Research & Development Division are: - Location, collection, processing and distribution of information concerning local and international research funding - Assistance in locating appropriate funding sources for Technion researchers - R&D information management services and in-campus marketing - Guidance and administrative services for Technion researchers in submitting research proposals to granting agencies and business entities - Management of contractual engagements with granting agencies and business entities - Contractual and budgetary administration of research grants and other accounts

Riken Corp. engages in the manufacture and sale of engine and vehicular components. It operates through the Automotive and Machinery Parts, and Others segments. The Automotive and Machinery Parts segment deals with the company's core products such as piston rings, camshafts, seal rings for transmissions, high-grade cast iron products, and valve lifters. The Others segment includes plumbing equipment business, Electromagnetic Compatibility (EMC) business, and thermal engineering business, The company was founded by Masatoshi Okochi in November 1927 and is headquartered in Tokyo, Japan.

xFOREST Therapeutics provides technology platforms that integrate massively parallel biochemical analysis systems for species of RNA structures and in silico analysis pipelines. Their analyses include various RNA structures, regardless of their source organ, species, or virus.

Takara Bio Inc., develops, manufactures, and distributes a wide range of life science reagents and kits under the Takara®, Clontech®, and Cellartis® brands. Key products include SMART® cDNA synthesis kits for a variety of samples and applications, including NGS; high-performance qPCR and PCR reagents (including the Takara Ex Taq®, Takara LA Taq®, Titanium®, and Advantage® enzymes); Cellartis stem cells and stem cell reagents; RT enzymes and SMART library construction kits; the innovative In-Fusion® cloning system; Guide-it™ gene editing tools; Tet-based inducible gene expression systems; and Living Colors® fluorescent proteins. These and other products support applications including NGS; gene discovery, regulation, and function studies; protein expression and purification; RNAi, gene editing, and stem cell studies; and plant and food research

The personalized diagnosis, prognosis and treatment management of cardiovascular diseases, cancer, acute renal failure and hepatic pathology or asthma, among others, could be known sooner by measuring biomarkers linked to these diseases. Mirnax Biosens, S.L. is a biotechnology company, owned by Canaan Research & Investment, focused on development of new disruptive technologies based on liquid biopsy in area of clinical diagnosis and prognosis. MIRNAX is developing an universal and innovative platform of genetic biomarkers validation which have different biological nature (DNA, RNA, miRNAs, lncRNA, etc.) to market a technology, based on microqPCR, that can give a personalized diagnosis and prognosis response in a fast and effective way. This new technology of Mirnax gives rise to the development of different diagnosis and prognosis kits which are unique and innovative in the current market and they generate a personalized response to each patient. Our society owns several biomarker signatures with clinical value and excellent commercial perspectives. They allow the development of kits for pathologies with high incidence in current population and pathologies without diagnosis and prognosis options. Among them, there is a biomarkers group biomarkers to detecting Acute Kidney Injury in the early stages, which has been developed in collaboration with IRYCIS; a biomarker to know treatment response in patients with Rheumatoid Arthritis, of IMIBIC and a biomarker to diagnosis asthma and patients stratification, of Jimenez Diaz Foundation. In addition, MIRNAX has developed, in collaboration with Complutense University of Madrid, automated equipment (electrochemical biosensor). With it, several blood biomarkers have been validated for diseases such as cancer, cardiomyopathies, rheumatoid arthritis, asthma, kidney injury or liver failure, as well as another groups of biomarkers to detect oral cancer (mouth, lips, tongue or salivary glands cancer) directly from a sample of spit.

Syngene Ltd. is a private company headquartered in Toorak, Australia. The firm holds licences for use of synthetic genetic molecules and their application as gene diagnostics or as antisense pharmaceuticals.